FC
Farallon Capital Management, L.L.C. cut its ENTA stake below 5%
Farallon Capital Management, L.L.C. reported owning 3.3% of Enanta Pharmaceuticals Inc (ENTA) (950,000 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G